Exploring the use of adalimumab for patients with moderate Crohn's disease: subanalyses from induction and maintenance trials.
about
Adalimumab treatment in Crohn's disease: an overview of long-term efficacy and safety in light of the EXTEND trialImpact of patient characteristics on the clinical efficacy of mongersen (GED-0301), an oral Smad7 antisense oligonucleotide, in active Crohn's disease.Tailoring anti-TNF therapy in IBD: drug levels and disease activity.Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.Risk Stratification for Surgery in Stricturing Ileal Crohn's Disease: The BACARDI Risk Model.A Review of the Landscape of Targeted Immunomodulatory Therapies for Non-Infectious Uveitis.
P2860
Exploring the use of adalimumab for patients with moderate Crohn's disease: subanalyses from induction and maintenance trials.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Exploring the use of adalimuma ...... uction and maintenance trials.
@en
Exploring the use of adalimuma ...... uction and maintenance trials.
@nl
type
label
Exploring the use of adalimuma ...... uction and maintenance trials.
@en
Exploring the use of adalimuma ...... uction and maintenance trials.
@nl
prefLabel
Exploring the use of adalimuma ...... uction and maintenance trials.
@en
Exploring the use of adalimuma ...... uction and maintenance trials.
@nl
P2093
P2860
P50
P1476
Exploring the use of adalimuma ...... uction and maintenance trials.
@en
P2093
Anne M Robinson
Majin Castillo
Roopal Thakkar
P2860
P304
P356
10.1016/J.CROHNS.2013.02.016
P577
2013-03-18T00:00:00Z